Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;32(4):187-91.
doi: 10.4103/0971-5851.95138.

Epidemiology of musculoskeletal tumors in Shiraz, south of Iran

Affiliations

Epidemiology of musculoskeletal tumors in Shiraz, south of Iran

Saeed Solooki et al. Indian J Med Paediatr Oncol. 2011 Oct.

Abstract

Background: Musculoskeletal tumors are rare, but their descriptive data in any region are important to reduce mortality rate and improve their management.

Materials and methods: Retrospectively, 426 pathologic reports from 1997 to 2008 were reviewed in Shiraz University Orthopedic Hospitals which are the main referral centers for musculoskeletal tumors in south of Iran. We collected and analyzed data on age, gender, anatomical site, and histopathologic types of musculoskeletal tumors.

Results: Of the 426 cases, 60.1% were men and 39.9% were women. The commonest malignant bone tumors were osteosarcoma (89; 50.6%), metastasis (30; 17.0%), Ewing's sarcoma (28; 15.9%), and chondrosarcoma (14; 8.0%). The most frequent benign bone tumors were osteochondroma (136; 63.9%), enchondroma (23; 10.8%), giant cell tumor (21; 9.9%), and osteoid osteoma (14; 6.6%). The femur was the most commonly involved site in musculoskeletal tumors. It was followed by the tibia in benign tumors and the humerus in malignant ones. Metastasis (28; 32.6%), soft tissue tumors (18; 20.9%), osteochondroma (10; 11.6%), and osteosarcoma (9; 10.5%) were the most diagnosed bone lesions in patients older than 40.

Conclusion: There are no significant changes in epidemiology of musculoskeletal tumors in Shiraz, south of Iran, in comparison with other parts of the world.

Keywords: Benign; Iran; Shiraz; bone; malignancy; musculoskeletal; tumor.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:6243s–9s. - PubMed
    1. Lewis VO. What's new in musculoskeletal oncology. J Bone Joint Surg Am. 2007;89:1399–407. - PubMed
    1. Fletcher CD, Unni KK, Mertens F, editors. of World Health Organization classification of tumours. Vol. 5. Lyon, France: IARC Press; 2002. Pathology and genetics of tumours of soft tissue and bone.
    1. Stiller CA, Bielack SS, Jundt G, Steliarova-Foucher E. Bone tumours in European children and adolescents, 1978-1997.Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2124–35. - PubMed
    1. Bramer JA, Somford MP. The epidemiology of primary skeletal malignancy. Orthop Trauma. 2010;24:247–51.